SCHEMBL18197832

SCHEMBL18197832

Nc1cc(Cl)c2ccc3ccccc3c2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.65
MAPT P10636 2/20 0.65
CCR1 P32246 1/20 0.43
CCR8 P51685 1/20 0.43
HPRT1 P00492 2/20 0.43
CYP2A6 P11509 3/20 0.42
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP1B1 Q16678 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP1A1 P04798 2/20 0.41
MAOA P21397 1/20 0.41
ITGB2 P05107 1/20 0.40
ICAM1 P05362 1/20 0.40
ITGAL P20701 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
APEX1 P27695 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29498093 0.81 MAPT (0.69) L3MBTL1MAPTCCR1CCR8HPRT1
SCHEMBL8140334 0.81 MAPT (0.69) L3MBTL1MAPTCCR1CCR8HPRT1
SCHEMBL13906866 0.79 NR4A2 (0.56) L3MBTL1MAPTCCR1CCR8CYP2A6
SCHEMBL22686771 0.76 L3MBTL1 (0.61) L3MBTL1MAPTCCR1CCR8CYP2A6
SCHEMBL21658782 0.75 NR4A2 (0.40) L3MBTL1MAPTCCR1CCR8ALDH1A1
SCHEMBL18197787 0.75 NR4A2 (0.47) L3MBTL1MAPTCCR1CCR8ALDH1A1
SCHEMBL27299384 0.75 PLAU (0.50) L3MBTL1MAPTCCR1CCR8ALDH1A1
SCHEMBL27571287 0.75 NCF1 (0.53) HPRT1CYP2A6ALDH1A1CYP1B1CYP3A4
SCHEMBL21556238 0.75 MAPT (0.64) L3MBTL1MAPTCCR1CCR8HPRT1
SCHEMBL1845197 0.73 BACE1 (0.60) MAPTALDH1A1RAB9AMAOALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3088397-A1 COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER Canbas Co. Ltd. (JP) 2016-11-02 EP disclosed